Given that activation of the circadian clock in B16 tumors triggered rhythms of cell cycle genes and phases, we then evaluated whether the activation of clock function in B16 tumors was paralleled by a reduction in tumor growth. The gene discussed is CLOCK; the disease is neoplasm.